Our Pipeline
Prosemble’s drug pipeline is built on the synergy of AI-driven discovery and cutting-edge nanotechnology, aiming to redefine cancer treatment.
Next-Generation Drug Delivery
Harnessing AI and nanotechnology to improve precision, efficacy, and safety in cancer treatment.
Targeted & Responsive Therapies
Our platform ensures controlled drug release, minimising toxicity and maximising therapeutic impact.
Scalable & Cost-Effective Solutions
Innovative nanoparticle technology provides a more accessible alternative to traditional oncology treatments.
Our Pipeline
Doxorubicin
- Interferes with the growth and spread of cancer cells.
- Works on breast cancer, bladder cancer, Kaposi’s sarcoma, lymphoma, and acute lymphoblastic leukaemia.
Cisplatin
- Causes DNA damage inhibiting replication of cancer cells.
- Works on testicular, ovarian, bladder, lung, stomach, and head and neck cancers.
Docetaxel
- Inhibits cell division, leading to the death of cancer cells.
- Works on breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancers.
Cyclophosphamide
- Interferes with the growth and replication of rapidly dividing cells.
- Works on leukaemia, lymphoma, breast, ovarian, and certain childhood cancers.
Methotrexate
- Inhibits enzyme dihydrofolate reductase, which is essential for DNA synthesis and cell replication.
- Works on leukaemia, lymphoma, and certain types of solid tumours.
Vinorelbine
- Inhibits the assembly of microtubules, thus preventing cell division.
- Works on non-small cell lung cancer and metastatic breast cancer.
siRNA Molecule
- Silences gene expression by degrading mRNA molecules with complementary sequences, preventing the production of specific proteins.
Through Our Science We Are Transforming Cancer Treatment for Chemotherapy Patients
